11 Best New Penny Stocks to Buy Right Now

Page 2 of 10

9. Kyverna Therapeutics, Inc. (NASDAQ:KYTX)

Share Price: $4.33

Number of Hedge Fund Holders: 10

Kyverna Therapeutics, Inc. (NASDAQ:KYTX) is one of the best new penny stocks to buy right now. On June 30, Kyverna Therapeutics, Inc. (NASDAQ:KYTX) announced that Marc Grasso, M.D. has been appointed as the company’s new Chief Financial Officer (CFO).

Before joining Kyverna Therapeutics, Inc. (NASDAQ:KYTX), Dr. Grasso was serving as CFO at Alector, Inc., a biotechnology company focused on neurodegenerative diseases. There, he oversaw financial planning, investor relations, accounting, IT, and facilities. Dr. Grasso earned his medical degree from Johns Hopkins University School of Medicine, where he also performed research in molecular oncology. He holds a Bachelor of Arts degree in molecular biology with honors from Princeton University.

Dr. Grasso has over 25 years of experience working with public companies, capital markets, and investment banking. He is taking over from Ryan Jones, MBA, who is moving to a strategic advisor role to help with a smooth transition.

The new CFO is expected to use his experience to help Kyverna Therapeutics, Inc. (NASDAQ:KYTX) bring the first CAR T-cell therapy for autoimmune diseases to the market while also guiding the company’s business and financial plans.

As Kyverna Therapeutics, Inc. (NASDAQ:KYTX) works to speed up its clinical development and commercialization efforts, Dr. Grasso’s leadership will play a crucial role in supporting the company’s next phase of growth.

Kyverna Therapeutics, Inc. (NASDAQ:KYTX) is a clinical-stage biopharmaceutical company committed to developing cell therapies for patients suffering from autoimmune diseases.

Page 2 of 10